16-56667365-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001301267.2(MT1G):c.44C>A(p.Thr15Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000173 in 1,614,252 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001301267.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MT1G | ENST00000379811.4 | c.44C>A | p.Thr15Asn | missense_variant | Exon 2 of 3 | 1 | NM_001301267.2 | ENSP00000369139.4 | ||
MT1G | ENST00000444837.6 | c.41C>A | p.Thr14Asn | missense_variant | Exon 2 of 3 | 1 | ENSP00000391397.2 | |||
MT1G | ENST00000568675.1 | n.69C>A | non_coding_transcript_exon_variant | Exon 2 of 2 | 1 | |||||
MT1G | ENST00000569500.5 | c.29-395C>A | intron_variant | Intron 1 of 1 | 3 | ENSP00000456675.1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152244Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251428Hom.: 0 AF XY: 0.0000441 AC XY: 6AN XY: 135916
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461890Hom.: 0 Cov.: 31 AF XY: 0.00000413 AC XY: 3AN XY: 727246
GnomAD4 genome AF: 0.000144 AC: 22AN: 152362Hom.: 0 Cov.: 33 AF XY: 0.000161 AC XY: 12AN XY: 74500
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.41C>A (p.T14N) alteration is located in exon 2 (coding exon 2) of the MT1G gene. This alteration results from a C to A substitution at nucleotide position 41, causing the threonine (T) at amino acid position 14 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at